In the high-stakes world of Chinese television and web dramas, where massive budgets, passionate fandoms, and celebrity egos collide, something as seemingly mundane as the order of names in the credits has long been a flashpoint. On June 12, 2026, three major industry bodies—the China Television Drama Production Industry Association, the China Netcasting Services Association, and the Actor Committee of the China Radio and Television Social Organizations Federation—jointly released new guidelines to standardize actor credits. The rules take effect July 10, 2026, after a short transition period, applying to all newly released TV dramas and web series.
The Roots of the Controversy: Why Credits Matter So Much
At its core, the “billing wars” (often called fanwei disputes in Chinese industry speak) stem from the intense commercialization of the industry. In Chinese dramas, the order of names on opening credits, posters, trailers, and promotional materials isn’t just symbolic prestige—it’s a visible marker of status that influences everything from fan perception to future opportunities.
Fans obsess over who gets “first billing” because it signals who the production views as the true lead. This matters enormously in a fandom-driven market: agencies and platforms worry that slighting a top star’s fans could lead to boycotts, poor promotion, or social media backlash that tanks viewership metrics. Disagreements often erupt during casting, contract talks, filming, and even post-production, sometimes resulting in script changes, delayed releases, or outright project halts. Public feuds have spilled into fan wars, with accusations of unequal screen time, manipulated posters, or broken promises.
High-profile examples illustrate the damage. Past cases like the Golden Hairpin dispute between Yang Zi and Kris Wu escalated into ugly fan conflicts and contributed to broader project issues. In Ace Troops, alleged billing imbalances led to quiet boycotts and rebalancing efforts. These aren’t isolated incidents; they reflect deeper tensions in an industry where celebrity power, sponsorships, and data-driven success metrics amplify every perceived slight.
Custom Titles and Made Up Hierarchies
These were fancy, non-standard credit labels invented on a per-project basis. Instead of sticking to straightforward roles like “Lead Actor” or “Supporting Cast,” productions cooked up elevated-sounding titles to make actors (and especially their fans) feel special. The goal? Give the illusion of higher status without necessarily giving more screen time or pay.
Common examples included:
- Special Lead (Te Bie Zhu Yan or similar variations)
- Specially Invited Star (Te Yao Ming Xing)
- Specially Invited Appearance (Te Yao Chu Yan)
- Honorary Appearance or Friend Actor (used for surprise big-name drops)
- Co-Starring, Invited Starring, Special Starring, and endless hybrids
These weren’t just for posters — they appeared in opening credits, trailers, press releases, and social media promos. The more titles, the more “star power” the project could claim.
One classic case was the 2021 drama Luoyang (风起洛阳). Its promotional materials featured a wild mix: Special Lead, Specially Invited Star, Specially Invited Appearance, and Special Appearance all on the same poster for different actors. It was a visual buffet of hierarchy that left audiences scratching their heads about who was actually leading what.
Another notorious example came with Sword Snow Stride (雪中悍刀行, sometimes referenced as Sward Snow Stride in discussions). Reports highlighted how nearly the entire cast was credited with some form of “starring” title — three leading starring actors, three special starring, seven invited starring, and eight co-starring. Netizens jokingly called it “wholesale starring,” a clear sign of producers bending over backward to satisfy multiple agencies and fanbases at once.
You’d also see patterns like:
- A mid-tier actor getting “Special Lead” billing to justify their fee or draw in their fandom.
- Veteran actors or A-listers making brief appearances but receiving “Specially Invited Star” treatment to boost prestige.
- Multiple “leads” in ensemble casts, where the actual protagonist role got diluted across several inflated titles.
This system turned credits into a negotiation battlefield. Bigger names demanded top spots or custom labels; smaller ones pushed for anything that sounded better than plain “Cast Member.” It resulted to projects delayed over poster approvals, script tweaks to justify screen time, and public spats that spilled onto Weibo.
Financial Implications: Far More Than Just Prominence
Is it purely about ego and “face”? Not at all. Billing carries real financial weight. Top billing often correlates with higher appearance fees, better contract terms, stronger platform backing, and enhanced commercial value for endorsements and future roles. Producers leverage star power for investment and pre-sales, while agencies fight hard because a star’s “rank” affects their marketability long-term.
In extreme cases, disputes tie into broader issues like unequal pay structures, “yin-yang contracts” (dual contracts for tax evasion, which regulators have cracked down on before), or inflated salaries that strain production budgets. Past government interventions capped actor pay at 40% of total costs precisely because superstar fees were distorting the economics and promoting “money worship.” The new rules build on that legacy of reining in excesses.
Why Regulators Stepped In: A Tipping Point of Chaos
China’s entertainment regulators have a history of intervening when industry practices threaten stability, cultural values, or economic efficiency—think past salary caps, celebrity ranking bans, and fan culture cleanups. The billing disputes reached a tipping point through repeated production delays, public scandals, and fan-driven online toxicity that disrupted workflows and damaged the industry’s image. With dramas being a key soft power and economic driver, constant internal bickering wasn’t sustainable.
The associations framed the move as shifting focus back to “artistic creation” rather than celebrity hierarchies. Actors and agencies are now explicitly encouraged to prioritize professional ethics, guide fans toward rational behavior, and avoid fanning online conflicts. It’s part of a broader push for order in a hyper-competitive sector.
What the New Regulation Actually Changes
The guidelines introduce clear, objective standards to minimize subjectivity and negotiation drama:
- Standardized Titles Only: Just three categories allowed—Leading Actor, Special Appearance, and Cast Member. No more custom titles or inflated hierarchies.
- Objective Ordering: Within the same category, names are listed by the stroke count of actors’ legal surnames in Chinese characters (fewer strokes first). Compound surnames use the first character; ethnic minority names follow ID registration. This draws on a traditional system used in official lists for neutrality.
- Legal Names Required: Productions must use performers’ real (legally registered) names. Widely known stage names can appear alongside in a standardized format. This promotes transparency and has already sparked online interest in celebrities’ real names.
- Broad Application: Rules cover opening/closing credits and all promotional materials—posters, trailers, press releases, social media, and offline events—for full consistency.
These changes aim to depersonalize decisions that once hinged on popularity, investment, or clout, reducing leverage for endless haggling.
Who Gets Affected?
Top-Tier and Mid-Tier Actors/Agencies: Those accustomed to battling for top spots via fan power or deals will face the biggest adjustment. Stars with complex surnames might see their names lower in lists, while simpler ones (e.g., “Wang” or “Li”) gain a slight edge in ties—though categories still reflect role importance.
Productions and Platforms: Easier casting and fewer delays. Teams can focus more on quality storytelling than credit negotiations. Platforms like iQiyi or Tencent Video benefit from smoother rollouts.
Fans: Encouraged toward less toxic behavior, though some may resist changes affecting their idols. The rules explicitly task agencies with guiding rational fandom.
Emerging Talent: Potentially more room to shine without rigid hierarchies blocking opportunities, though proven commercial value will still matter for leading roles.
The Industry Overall: A step toward professionalism, aligning with ongoing efforts to clean up fan culture, control costs, and emphasize substance over hype.
This isn’t the first regulatory nudge—earlier rules tied credits to contracts—but the specificity and enforcement push signal seriousness. As the July 10 deadline approaches, expect some transitional grumbling, but the goal is clear: let the work speak louder than the names above the title. In an industry famous for its intensity, dialing down one source of drama might just allow more compelling stories to emerge.
What do you think—will stroke count truly bring peace, or are deeper cultural shifts needed? Stay tuned for how productions adapt.
